{"product_id":"wc-0efe51bcb5f34c14-51087","title":"Continuing Education Company 19th Annual Primary Care Spring Conference 2025","description":"\u003ch1 data-pm-slice=\"1 1 []\"\u003eCEC 19th Annual Primary Care Spring Conference 2025\u003c\/h1\u003e\r\n\u003ch2\u003eContinuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I | Internal Medicine, Family Medicine, Hepatology, Infectious Diseases, Women's Health, Cardiology, Psychiatry, Gastroenterology \u0026amp; Neurology\u003c\/h2\u003e\r\nThe \u003cstrong\u003eContinuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I\u003c\/strong\u003e provides a comprehensive, evidence-based educational update on common and complex medical conditions encountered in family medicine, internal medicine, and outpatient primary care.\r\n\r\nOrganized by \u003cstrong\u003eContinuing Education Company, Inc. (CEC)\u003c\/strong\u003e, this five-day medical education conference brings together experienced clinical faculty to review current diagnostic approaches, evolving therapeutic guidelines, newer medications, and practical strategies for improving patient outcomes.\r\n\r\nHeld from \u003cstrong\u003eMarch 31 to April 4, 2025\u003c\/strong\u003e, at Hammock Beach Golf Resort \u0026amp; Spa in Palm Coast, Florida, with in-person and live webcast attendance options, the conference focuses on clinically relevant developments across hepatology, infectious diseases, women's health, urogynecology, cardiology, hypertension, pharmacology, emergency medicine, vascular medicine, psychiatry, gastroenterology, and neurology.\r\n\r\nThe \u003cstrong\u003eCEC Primary Care Spring Conference 2025\u003c\/strong\u003e curriculum examines elevated liver function tests, metabolic dysfunction-associated steatotic liver disease (MASLD), appropriate antibiotic prescribing, cellulitis, cardiovascular disease risk in midlife women, menopause, overactive bladder, postpartum pelvic symptoms, resistant hypertension, syncope, venous thromboembolism, new drug therapies, depression, psychiatric medication adverse effects, gastroesophageal reflux disease (GERD), dementia, and Alzheimer's disease.\r\n\r\nThe program emphasizes integrating current research, diagnostic reasoning, clinical guidelines, and individualized patient management into everyday primary care practice.\r\n\r\nThrough expert lectures, case-based education, and interactive pharmacology discussions, the conference supports practical continuing education for physicians and other healthcare professionals.\r\n\u003ch2\u003eCourse Details\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e CEC 19th Annual Primary Care Spring Conference 2025\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Event:\u003c\/strong\u003e 19th Annual Primary Care Spring Conference – Session I\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOrganizer:\u003c\/strong\u003e Continuing Education Company, Inc. (CEC)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDates:\u003c\/strong\u003e March 31 – April 4, 2025\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLocation:\u003c\/strong\u003e Palm Coast, Florida, USA\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eVenue:\u003c\/strong\u003e Hammock Beach Golf Resort \u0026amp; Spa\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Format:\u003c\/strong\u003e In-Person and Live Streaming Webcast\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Five Days\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Schedule:\u003c\/strong\u003e 7:55 AM – 12:15 PM Eastern Time\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eScheduled Educational Content:\u003c\/strong\u003e 20 Hours\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePrimary Specialty:\u003c\/strong\u003e Family Medicine \/ Primary Care\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAdditional Focus:\u003c\/strong\u003e Internal Medicine, Hepatology, Infectious Diseases, Women's Health, Urology, Cardiology, Pharmacology, Psychiatry, Gastroenterology and Neurology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePublished Scientific Lectures:\u003c\/strong\u003e 19\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAdditional Educational Session:\u003c\/strong\u003e Pharmacology Expert Q\u0026amp;A\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Conference CME:\u003c\/strong\u003e Up to 20 CME Credits, subject to provider requirements\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eMedicalAmboss Listed Format:\u003c\/strong\u003e Videos + Slides\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe original conference offered continuing education credits to eligible registered attendees. Official credits, certificates, conference registration, and publisher platform access are not included with separately distributed MedicalAmboss files.\r\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\r\nThe program is intended for healthcare professionals involved in the diagnosis, treatment, and long-term management of patients in outpatient and primary care settings.\r\n\r\nThe target audience includes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eGeneral Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eHospitalists\u003c\/li\u003e\r\n \t\u003cli\u003eHepatologists\u003c\/li\u003e\r\n \t\u003cli\u003eGastroenterologists\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Disease Specialists\u003c\/li\u003e\r\n \t\u003cli\u003eCardiologists\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologists\u003c\/li\u003e\r\n \t\u003cli\u003eObstetricians and Gynecologists\u003c\/li\u003e\r\n \t\u003cli\u003eUrologists\u003c\/li\u003e\r\n \t\u003cli\u003eUrogynecologists\u003c\/li\u003e\r\n \t\u003cli\u003eEmergency Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eHematologists\u003c\/li\u003e\r\n \t\u003cli\u003ePulmonologists\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatrists\u003c\/li\u003e\r\n \t\u003cli\u003eNeurologists\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pharmacists\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced Practice Providers\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Residents\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eOther Healthcare Professionals Involved in Primary Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe conference is particularly relevant to clinicians seeking practical updates on chronic disease management, preventive medicine, medication safety, women's health, and evidence-based outpatient care.\r\n\u003ch2\u003eProgram Overview\u003c\/h2\u003e\r\nPrimary care clinicians routinely evaluate patients with multiple medical conditions requiring accurate diagnosis, appropriate investigation, and individualized treatment.\r\n\r\nThe \u003cstrong\u003e19th Annual Primary Care Spring Conference 2025 – Session I\u003c\/strong\u003e addresses important changes in medical practice through focused specialty presentations and practical clinical reviews.\r\n\r\nThe curriculum covers:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eElevated Liver Function Tests\u003c\/li\u003e\r\n \t\u003cli\u003eAbnormal Liver Enzymes\u003c\/li\u003e\r\n \t\u003cli\u003eMASLD\u003c\/li\u003e\r\n \t\u003cli\u003eAntibiotic Stewardship\u003c\/li\u003e\r\n \t\u003cli\u003eCommon Outpatient Infections\u003c\/li\u003e\r\n \t\u003cli\u003eCellulitis\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular Risk in Midlife Women\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause Management\u003c\/li\u003e\r\n \t\u003cli\u003eVasomotor Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eGenitourinary Syndrome of Menopause\u003c\/li\u003e\r\n \t\u003cli\u003eOveractive Bladder\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Pelvic Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension\u003c\/li\u003e\r\n \t\u003cli\u003eResistant Hypertension\u003c\/li\u003e\r\n \t\u003cli\u003eNew Drug Therapies\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pharmacology\u003c\/li\u003e\r\n \t\u003cli\u003eSyncope\u003c\/li\u003e\r\n \t\u003cli\u003eVenous Thromboembolism\u003c\/li\u003e\r\n \t\u003cli\u003eD-Dimer Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDeep Vein Thrombosis\u003c\/li\u003e\r\n \t\u003cli\u003ePulmonary Embolism\u003c\/li\u003e\r\n \t\u003cli\u003eDepression\u003c\/li\u003e\r\n \t\u003cli\u003eAntidepressant Therapy\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Medication Adverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eGERD\u003c\/li\u003e\r\n \t\u003cli\u003eExtraesophageal Reflux\u003c\/li\u003e\r\n \t\u003cli\u003eDementia\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Primary Care\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Decision-Making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program integrates clinical assessment, medical management, risk reduction, preventive care, and current treatment recommendations.\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\nAs a result of participating in the original conference, learners should be better able to:\r\n\u003col start=\"1\" data-spread=\"true\"\u003e\r\n \t\u003cli\u003eAssess and provide patients with accurate diagnoses and optimal care for a broad range of disorders commonly seen in primary care.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize current clinical guidelines in the diagnosis and management of frequently encountered therapeutic problems.\u003c\/li\u003e\r\n \t\u003cli\u003eFormulate comprehensive evidence-based interventions and treatment strategies to reduce modifiable risk factors and improve long-term patient outcomes.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate elevated liver function tests and recognize metabolic dysfunction-associated steatotic liver disease.\u003c\/li\u003e\r\n \t\u003cli\u003eApply evidence-based approaches to antibiotic selection and the management of common outpatient infections, including cellulitis.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess cardiovascular risk in midlife women and review management strategies for menopausal symptoms.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate overactive bladder and postpartum pelvic symptoms encountered in primary care.\u003c\/li\u003e\r\n \t\u003cli\u003eApply contemporary recommendations to hypertension assessment and management, including resistant hypertension.\u003c\/li\u003e\r\n \t\u003cli\u003eReview emerging pharmacological treatments and recognize important medication safety considerations.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop appropriate diagnostic approaches to syncope and suspected venous thromboembolism.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate treatment options for depression and recognize adverse effects associated with psychiatric medications.\u003c\/li\u003e\r\n \t\u003cli\u003eReview diagnostic and treatment strategies for GERD and extraesophageal reflux.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize cognitive impairment, evaluate suspected dementia, and consider appropriate management of Alzheimer's disease.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\nThe first three objectives reflect the organizer's general conference objectives. The remaining objectives elaborate on the published Session I lecture topics.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eOfficial Program Topics\u003c\/h1\u003e\r\n\u003ch2\u003eDay 1 – Monday, March 31, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eConference Announcements\u003c\/h3\u003e\r\n\u003cstrong\u003e7:55 AM – 8:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Ejnes, CHCP\r\n\r\nOpening announcements and orientation to the educational program.\r\n\u003ch2\u003eSession I – Hepatology\u003c\/h2\u003e\r\n\u003ch3\u003eBoot Camp for Elevated Liver Function Tests\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 9:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e P. Buch, MD\r\n\r\nThis session examines the clinical evaluation of abnormal liver function tests, a frequently encountered issue in primary care and internal medicine.\r\n\r\nImportant clinical considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eElevated Liver Enzymes\u003c\/li\u003e\r\n \t\u003cli\u003eAbnormal Aminotransferases\u003c\/li\u003e\r\n \t\u003cli\u003eHepatocellular Injury\u003c\/li\u003e\r\n \t\u003cli\u003eCholestatic Liver Test Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003eMedication-Related Liver Injury\u003c\/li\u003e\r\n \t\u003cli\u003eAlcohol-Associated Liver Disease\u003c\/li\u003e\r\n \t\u003cli\u003eViral Hepatitis\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Liver Disease\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Laboratory Testing\u003c\/li\u003e\r\n \t\u003cli\u003eImaging Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eHepatology Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus is on developing a systematic approach to abnormal liver test results and selecting appropriate investigations.\r\n\u003ch3\u003eMetabolic Dysfunction Associated Steatotic Liver Disease (MASLD)\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 10:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e P. Buch, MD\r\n\r\nThis presentation reviews metabolic dysfunction-associated steatotic liver disease and its relevance to modern primary care.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMASLD\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eObesity\u003c\/li\u003e\r\n \t\u003cli\u003eType 2 Diabetes\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin Resistance\u003c\/li\u003e\r\n \t\u003cli\u003eHepatic Steatosis\u003c\/li\u003e\r\n \t\u003cli\u003eLiver Fibrosis\u003c\/li\u003e\r\n \t\u003cli\u003eNoninvasive Liver Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eCardiometabolic Risk\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Management\u003c\/li\u003e\r\n \t\u003cli\u003eWeight Reduction\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eReferral Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session addresses current clinical concepts in the recognition and management of metabolic liver disease.\r\n\u003ch2\u003eSession II – Infectious Diseases\u003c\/h2\u003e\r\n\u003ch3\u003eMore Head to Toe Antibiotics: Treatment Decisions for Common Outpatient Infections\u003c\/h3\u003e\r\n\u003cstrong\u003e10:15 AM – 11:15 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e A. Urban, MD\r\n\r\nThis presentation examines antibiotic treatment decisions for common infections encountered in outpatient clinical practice.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCommon Outpatient Infections\u003c\/li\u003e\r\n \t\u003cli\u003eAntibiotic Selection\u003c\/li\u003e\r\n \t\u003cli\u003eAntimicrobial Stewardship\u003c\/li\u003e\r\n \t\u003cli\u003eBacterial Infections\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eEmpiric Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eAntibiotic Resistance\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Duration\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Allergies\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Specific Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eAvoiding Unnecessary Antibiotic Use\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes responsible prescribing and evidence-based antimicrobial management.\r\n\u003ch3\u003eCellulitis in Adults: Improving Care and Calming a Red Hot Literature\u003c\/h3\u003e\r\n\u003cstrong\u003e11:15 AM – 12:15 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e A. Urban, MD\r\n\r\nThis session reviews current approaches to diagnosing and managing cellulitis in adult patients.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCellulitis\u003c\/li\u003e\r\n \t\u003cli\u003eSkin and Soft Tissue Infections\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Presentation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eErysipelas\u003c\/li\u003e\r\n \t\u003cli\u003eAbscess Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eAntibiotic Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eMRSA Risk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Selection\u003c\/li\u003e\r\n \t\u003cli\u003eOutpatient Management\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Response\u003c\/li\u003e\r\n \t\u003cli\u003eIndications for Hospital Evaluation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation supports practical decision-making for adults presenting with suspected bacterial skin infections.\r\n\r\n\u003cstrong\u003e12:15 PM – Day 1 Adjournment\u003c\/strong\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 2 – Tuesday, April 1, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eConference Announcements\u003c\/h3\u003e\r\n\u003cstrong\u003e7:55 AM – 8:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Ejnes, CHCP\r\n\u003ch2\u003eSession III – Women's Cardiovascular Health\u003c\/h2\u003e\r\n\u003ch3\u003eTargeting Women at Risk of CVD at Midlife: A Challenge to the Physician\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 9:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e C. Shufelt, MD\r\n\r\nThis presentation examines cardiovascular disease risk assessment and prevention in midlife women.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCardiovascular Disease in Women\u003c\/li\u003e\r\n \t\u003cli\u003eMidlife Cardiovascular Risk\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Transitions\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eTraditional Cardiovascular Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eFemale-Specific Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension\u003c\/li\u003e\r\n \t\u003cli\u003eDyslipidemia\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Screening\u003c\/li\u003e\r\n \t\u003cli\u003eRisk Reduction\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Interventions\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Cardiovascular Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes recognizing cardiovascular risk factors that may be overlooked during routine primary care assessment.\r\n\u003ch3\u003eManagement of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 10:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e C. Shufelt, MD\r\n\r\nThis session reviews management of menopausal symptoms and genitourinary syndrome of menopause.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eVasomotor Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHot Flashes\u003c\/li\u003e\r\n \t\u003cli\u003eNight Sweats\u003c\/li\u003e\r\n \t\u003cli\u003eGenitourinary Syndrome of Menopause\u003c\/li\u003e\r\n \t\u003cli\u003eVaginal Dryness\u003c\/li\u003e\r\n \t\u003cli\u003eGenitourinary Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHormone Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eNonhormonal Treatment Options\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Safety\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Preferences\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes appropriate treatment selection based on clinical evidence and patient-specific circumstances.\r\n\u003ch2\u003eSession IV – Urology and Urogynecology\u003c\/h2\u003e\r\n\u003ch3\u003eHow to Address Overactive Bladder in Primary Care\u003c\/h3\u003e\r\n\u003cstrong\u003e10:15 AM – 11:15 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e L. Rogo-Gupta, MD\r\n\r\nThis presentation reviews evaluation and management of overactive bladder in primary care settings.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOveractive Bladder\u003c\/li\u003e\r\n \t\u003cli\u003eUrinary Urgency\u003c\/li\u003e\r\n \t\u003cli\u003eUrinary Frequency\u003c\/li\u003e\r\n \t\u003cli\u003eUrge Incontinence\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eBehavioral Interventions\u003c\/li\u003e\r\n \t\u003cli\u003eBladder Training\u003c\/li\u003e\r\n \t\u003cli\u003ePelvic Floor Therapy\u003c\/li\u003e\r\n \t\u003cli\u003ePharmacological Options\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment-Related Adverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eReferral to Urogynecology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes practical management approaches relevant to outpatient medicine.\r\n\u003ch3\u003eHow to Address Pelvic Symptoms in Postpartum Patients Transitioning Back to Primary Care\u003c\/h3\u003e\r\n\u003cstrong\u003e11:15 AM – 12:15 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e L. Rogo-Gupta, MD\r\n\r\nThis session examines pelvic symptoms affecting postpartum patients as they transition from obstetric care to primary care follow-up.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePostpartum Pelvic Health\u003c\/li\u003e\r\n \t\u003cli\u003ePelvic Floor Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eUrinary Incontinence\u003c\/li\u003e\r\n \t\u003cli\u003ePelvic Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Recovery\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003ePelvic Floor Rehabilitation\u003c\/li\u003e\r\n \t\u003cli\u003eSymptom Recognition\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Counseling\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Referral\u003c\/li\u003e\r\n \t\u003cli\u003eContinuity of Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes coordination between obstetric, primary care, and urogynecology services.\r\n\r\n\u003cstrong\u003e12:15 PM – Day 2 Adjournment\u003c\/strong\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 3 – Wednesday, April 2, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eConference Announcements\u003c\/h3\u003e\r\n\u003cstrong\u003e7:55 AM – 8:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Ejnes, CHCP\r\n\u003ch2\u003eSession V – Cardiology and Hypertension\u003c\/h2\u003e\r\n\u003ch3\u003eControversies in Hypertension: Testing What You Know\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 9:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e J. Basile, MD\r\n\r\nThis presentation reviews important controversies and evolving recommendations in hypertension management.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHypertension Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Pressure Measurement\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular Risk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Guidelines\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Thresholds\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Pressure Targets\u003c\/li\u003e\r\n \t\u003cli\u003eAntihypertensive Therapy\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Specific Treatment\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eRisk-Benefit Assessment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session examines areas where clinicians must interpret research and apply treatment recommendations to individual patients.\r\n\u003ch3\u003eResistant Hypertension: An Update\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 10:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e J. Basile, MD\r\n\r\nThis presentation reviews the assessment and treatment of resistant hypertension.\r\n\r\nImportant clinical topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eResistant Hypertension\u003c\/li\u003e\r\n \t\u003cli\u003eApparent Treatment Resistance\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Adherence\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Pressure Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eSecondary Hypertension\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary Aldosteronism\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Optimization\u003c\/li\u003e\r\n \t\u003cli\u003eCombination Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular Risk\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Factors\u003c\/li\u003e\r\n \t\u003cli\u003eSpecialist Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational emphasis is on systematic evaluation and appropriate management of persistent blood pressure elevation.\r\n\u003ch2\u003eSession VI – Clinical Pharmacology\u003c\/h2\u003e\r\n\u003ch3\u003eNew Drug Update\u003c\/h3\u003e\r\n\u003cstrong\u003e10:15 AM – 11:15 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Weart, PharmD\r\n\r\nThis presentation reviews recent developments in pharmacological therapies relevant to primary care.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNewly Available Medications\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic Advances\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Indications\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eContraindications\u003c\/li\u003e\r\n \t\u003cli\u003eAdverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Interactions\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribing Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Pharmacotherapy\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes the practical interpretation of new medication evidence.\r\n\u003ch3\u003eAsk the Expert: Pharmacology Q\u0026amp;A\u003c\/h3\u003e\r\n\u003cstrong\u003e11:15 AM – 12:15 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Weart, PharmD\r\n\r\nThis interactive session addresses clinical pharmacology questions arising in everyday patient care.\r\n\r\nRelevant themes include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMedication Selection\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Interactions\u003c\/li\u003e\r\n \t\u003cli\u003eAdverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Prescribing\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic Alternatives\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Specific Treatment Decisions\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003e12:15 PM – Day 3 Adjournment\u003c\/strong\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 4 – Thursday, April 3, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eConference Announcements\u003c\/h3\u003e\r\n\u003cstrong\u003e7:55 AM – 8:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Ejnes, CHCP\r\n\u003ch2\u003eSession VII – Emergency and Vascular Medicine\u003c\/h2\u003e\r\n\u003ch3\u003eSyncope: What to do When the Lights Go Out\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 9:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e R. Dachs, MD\r\n\r\nThis presentation reviews the evaluation of syncope and transient loss of consciousness.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSyncope\u003c\/li\u003e\r\n \t\u003cli\u003eTransient Loss of Consciousness\u003c\/li\u003e\r\n \t\u003cli\u003eVasovagal Syncope\u003c\/li\u003e\r\n \t\u003cli\u003eOrthostatic Hypotension\u003c\/li\u003e\r\n \t\u003cli\u003eCardiac Syncope\u003c\/li\u003e\r\n \t\u003cli\u003eArrhythmias\u003c\/li\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003ePhysical Examination\u003c\/li\u003e\r\n \t\u003cli\u003eElectrocardiography\u003c\/li\u003e\r\n \t\u003cli\u003eRisk Stratification\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Testing\u003c\/li\u003e\r\n \t\u003cli\u003eIndications for Emergency Evaluation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes distinguishing benign presentations from potentially serious causes.\r\n\u003ch3\u003eVenous Thromboembolism and the D-Dimer: 1) The Case of the Swollen Calf and 2) The Case of Pleuritic Chest Pain\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 10:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e R. Dachs, MD\r\n\r\nThis presentation examines diagnostic decision-making in patients with suspected venous thromboembolism.\r\n\r\nThe lecture uses two clinically relevant presentations:\r\n\r\n\u003cstrong\u003eThe Case of the Swollen Calf\u003c\/strong\u003e\r\n\r\nRelevant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDeep Vein Thrombosis\u003c\/li\u003e\r\n \t\u003cli\u003eLeg Swelling\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Probability\u003c\/li\u003e\r\n \t\u003cli\u003eD-Dimer Testing\u003c\/li\u003e\r\n \t\u003cli\u003eVenous Ultrasonography\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eThe Case of Pleuritic Chest Pain\u003c\/strong\u003e\r\n\r\nRelevant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePulmonary Embolism\u003c\/li\u003e\r\n \t\u003cli\u003ePleuritic Chest Pain\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Risk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eD-Dimer Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Imaging\u003c\/li\u003e\r\n \t\u003cli\u003eEmergency Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eAnticoagulation Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes appropriate use of clinical probability assessment and diagnostic testing.\r\n\u003ch2\u003eSession VIII – Psychiatry and Behavioral Health\u003c\/h2\u003e\r\n\u003ch3\u003eThe Treatment of Depression: SSRIs and Beyond\u003c\/h3\u003e\r\n\u003cstrong\u003e10:15 AM – 11:15 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e T. Heinrich, MD\r\n\r\nThis presentation reviews current approaches to depression treatment in primary care.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMajor Depressive Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eDepression Screening\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eSelective Serotonin Reuptake Inhibitors\u003c\/li\u003e\r\n \t\u003cli\u003eOther Antidepressant Classes\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Selection\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Response\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Adjustment\u003c\/li\u003e\r\n \t\u003cli\u003ePsychotherapy\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment-Resistant Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n \t\u003cli\u003eLong-Term Management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes individualized treatment planning and appropriate monitoring.\r\n\u003ch3\u003eSide Effects of Psychiatric Medications\u003c\/h3\u003e\r\n\u003cstrong\u003e11:15 AM – 12:15 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e T. Heinrich, MD\r\n\r\nThis session examines adverse effects associated with commonly prescribed psychiatric medications.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAntidepressant Adverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eAntipsychotic Medication Effects\u003c\/li\u003e\r\n \t\u003cli\u003eSedation\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Side Effects\u003c\/li\u003e\r\n \t\u003cli\u003eSexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Interactions\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Adherence\u003c\/li\u003e\r\n \t\u003cli\u003eRisk-Benefit Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation supports safer prescribing and recognition of treatment-related complications.\r\n\r\n\u003cstrong\u003e12:15 PM – Day 4 Adjournment\u003c\/strong\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 5 – Friday, April 4, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eConference Announcements\u003c\/h3\u003e\r\n\u003cstrong\u003e7:55 AM – 8:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e W. Ejnes, CHCP\r\n\u003ch2\u003eSession IX – Gastroenterology\u003c\/h2\u003e\r\n\u003ch3\u003eGERD and Extraesophageal GERD: How to Test and Treat?\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 10:00 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e M. Vaezi, MD\r\n\r\nThis extended presentation reviews gastroesophageal reflux disease and extraesophageal manifestations of reflux.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGastroesophageal Reflux Disease\u003c\/li\u003e\r\n \t\u003cli\u003eGERD Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHeartburn\u003c\/li\u003e\r\n \t\u003cli\u003eRegurgitation\u003c\/li\u003e\r\n \t\u003cli\u003eExtraesophageal Reflux\u003c\/li\u003e\r\n \t\u003cli\u003eChronic Cough\u003c\/li\u003e\r\n \t\u003cli\u003eLaryngopharyngeal Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eUpper Endoscopy\u003c\/li\u003e\r\n \t\u003cli\u003eAmbulatory Reflux Testing\u003c\/li\u003e\r\n \t\u003cli\u003eProton Pump Inhibitors\u003c\/li\u003e\r\n \t\u003cli\u003eNonpharmacological Management\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Selection\u003c\/li\u003e\r\n \t\u003cli\u003eRefractory Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eGastroenterology Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes evidence-based diagnostic testing and appropriate therapy.\r\n\u003ch2\u003eSession X – Neurology and Cognitive Disorders\u003c\/h2\u003e\r\n\u003ch3\u003eA True Clinic-based Approach to Dementia\u003c\/h3\u003e\r\n\u003cstrong\u003e10:15 AM – 11:15 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e G. Day, MD\r\n\r\nThis presentation reviews practical approaches to diagnosing cognitive impairment and dementia in primary care.\r\n\r\nImportant clinical considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCognitive Impairment\u003c\/li\u003e\r\n \t\u003cli\u003eDementia\u003c\/li\u003e\r\n \t\u003cli\u003eMemory Complaints\u003c\/li\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Screening\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Examination\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eReversible Contributors\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Investigations\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n \t\u003cli\u003eSpecialist Referral\u003c\/li\u003e\r\n \t\u003cli\u003eCaregiver Support\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes structured outpatient evaluation of patients with suspected cognitive disorders.\r\n\u003ch3\u003eClinical Findings and Approach to Management in Alzheimer Disease\u003c\/h3\u003e\r\n\u003cstrong\u003e11:15 AM – 12:15 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e G. Day, MD\r\n\r\nThis presentation examines Alzheimer's disease diagnosis and management.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Decline\u003c\/li\u003e\r\n \t\u003cli\u003eMemory Impairment\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Presentation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eBiomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eDisease Severity\u003c\/li\u003e\r\n \t\u003cli\u003eSymptomatic Treatment\u003c\/li\u003e\r\n \t\u003cli\u003eDisease-Modifying Treatment Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eCaregiver Education\u003c\/li\u003e\r\n \t\u003cli\u003eLong-Term Management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session reviews important clinical aspects of Alzheimer's disease in primary care.\r\n\r\n\u003cstrong\u003e12:15 PM – Conference Adjournment\u003c\/strong\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMajor Topics Covered\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eContinuing Education Company Primary Care Spring Conference 2025\u003c\/li\u003e\r\n \t\u003cli\u003eCEC 19th Annual Primary Care Spring Conference\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary Care\u003c\/li\u003e\r\n \t\u003cli\u003eHepatology\u003c\/li\u003e\r\n \t\u003cli\u003eElevated Liver Function Tests\u003c\/li\u003e\r\n \t\u003cli\u003eAbnormal Liver Enzymes\u003c\/li\u003e\r\n \t\u003cli\u003eMASLD\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Liver Disease\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Diseases\u003c\/li\u003e\r\n \t\u003cli\u003eAntibiotic Stewardship\u003c\/li\u003e\r\n \t\u003cli\u003eOutpatient Infection Management\u003c\/li\u003e\r\n \t\u003cli\u003eCellulitis\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Cardiovascular Health\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular Risk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eVasomotor Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eGenitourinary Syndrome of Menopause\u003c\/li\u003e\r\n \t\u003cli\u003eUrogynecology\u003c\/li\u003e\r\n \t\u003cli\u003eOveractive Bladder\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Pelvic Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension\u003c\/li\u003e\r\n \t\u003cli\u003eResistant Hypertension\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pharmacology\u003c\/li\u003e\r\n \t\u003cli\u003eNew Drug Therapies\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eSyncope\u003c\/li\u003e\r\n \t\u003cli\u003eVenous Thromboembolism\u003c\/li\u003e\r\n \t\u003cli\u003eDeep Vein Thrombosis\u003c\/li\u003e\r\n \t\u003cli\u003ePulmonary Embolism\u003c\/li\u003e\r\n \t\u003cli\u003eD-Dimer Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDepression\u003c\/li\u003e\r\n \t\u003cli\u003eAntidepressants\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Medication Side Effects\u003c\/li\u003e\r\n \t\u003cli\u003eGERD\u003c\/li\u003e\r\n \t\u003cli\u003eExtraesophageal Reflux\u003c\/li\u003e\r\n \t\u003cli\u003eDementia\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Medicine\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Primary Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eHepatology and Metabolic Liver Disease\u003c\/h2\u003e\r\nAbnormal liver function tests and metabolic liver disease are frequently encountered in primary care.\r\n\r\nThe conference includes dedicated presentations covering:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eElevated Liver Enzymes\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eLiver Disease Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eMASLD\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eFibrosis Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eLiver Disease Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese sessions support structured investigation and evidence-based management of common liver conditions.\r\n\u003ch2\u003eInfectious Diseases and Antibiotic Stewardship\u003c\/h2\u003e\r\nResponsible antibiotic prescribing is an important component of primary care practice.\r\n\r\nThe curriculum addresses the management of common outpatient infections and adult cellulitis.\r\n\r\nImportant considerations include antimicrobial resistance, treatment selection, infection severity, patient-specific risk factors, and avoiding unnecessary antibiotic exposure.\r\n\u003ch2\u003eWomen's Health and Midlife Cardiovascular Risk\u003c\/h2\u003e\r\nMidlife represents an important period for preventive healthcare in women.\r\n\r\nThe program examines cardiovascular risk, menopause, genitourinary symptoms, overactive bladder, and postpartum pelvic health.\r\n\r\nThe educational emphasis is on recognizing symptoms, applying current evidence, and coordinating appropriate patient care.\r\n\u003ch2\u003eHypertension and Cardiovascular Medicine\u003c\/h2\u003e\r\nHypertension remains an important contributor to cardiovascular morbidity.\r\n\r\nThe conference includes focused sessions on controversies in hypertension treatment and resistant hypertension.\r\n\r\nRelevant themes include blood pressure assessment, cardiovascular risk, secondary causes, medication adherence, treatment selection, and individualized management.\r\n\u003ch2\u003ePharmacology and Medication Safety\u003c\/h2\u003e\r\nNew medications and changing therapeutic recommendations present ongoing challenges for primary care clinicians.\r\n\r\nThe conference includes a new drug update and an interactive pharmacology session.\r\n\r\nThese sessions emphasize understanding clinical indications, medication safety, interactions, adverse effects, and evidence-based prescribing decisions.\r\n\u003ch2\u003eSyncope and Venous Thromboembolism\u003c\/h2\u003e\r\nSyncope, leg swelling, and pleuritic chest pain may require evaluation for serious cardiovascular or thromboembolic conditions.\r\n\r\nThe curriculum examines:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eClinical Risk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eElectrocardiography\u003c\/li\u003e\r\n \t\u003cli\u003eD-Dimer Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDeep Vein Thrombosis\u003c\/li\u003e\r\n \t\u003cli\u003ePulmonary Embolism\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Imaging\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese topics support accurate clinical assessment and timely identification of potentially serious disease.\r\n\u003ch2\u003eDepression and Psychiatric Medication Management\u003c\/h2\u003e\r\nDepression and psychiatric medication-related complications are frequently encountered in general medical practice.\r\n\r\nThe program reviews antidepressant treatment strategies, medication safety, and adverse effects.\r\n\r\nThe educational focus supports appropriate therapy selection, patient monitoring, and individualized management.\r\n\u003ch2\u003eGERD and Extraesophageal Reflux\u003c\/h2\u003e\r\nGastroesophageal reflux disease is a common gastrointestinal condition.\r\n\r\nThe course includes an extended presentation reviewing diagnosis and treatment of GERD and extraesophageal reflux.\r\n\r\nImportant considerations include symptom assessment, diagnostic testing, medical management, treatment response, and recognition of patients requiring additional gastroenterological evaluation.\r\n\u003ch2\u003eDementia and Alzheimer's Disease\u003c\/h2\u003e\r\nPrimary care physicians play an important role in the recognition and ongoing care of patients with cognitive disorders.\r\n\r\nThe curriculum includes two dedicated sessions addressing clinical assessment of dementia and Alzheimer's disease management.\r\n\r\nImportant topics include cognitive screening, differential diagnosis, diagnostic evaluation, clinical management, caregiver education, and long-term follow-up.\r\n\u003ch2\u003eEvidence-Based Clinical Decision-Making\u003c\/h2\u003e\r\nThe \u003cstrong\u003eCEC 19th Annual Primary Care Spring Conference 2025\u003c\/strong\u003e emphasizes translating evidence and practice recommendations into everyday medical care.\r\n\r\nImportant clinical responsibilities include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eRecognizing Important Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003ePerforming Appropriate Clinical Assessments\u003c\/li\u003e\r\n \t\u003cli\u003eEstablishing Differential Diagnoses\u003c\/li\u003e\r\n \t\u003cli\u003eSelecting Diagnostic Tests\u003c\/li\u003e\r\n \t\u003cli\u003eApplying Current Guidelines\u003c\/li\u003e\r\n \t\u003cli\u003eChoosing Appropriate Treatments\u003c\/li\u003e\r\n \t\u003cli\u003eManaging Medication Risks\u003c\/li\u003e\r\n \t\u003cli\u003eReducing Modifiable Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eCoordinating Specialist Referrals\u003c\/li\u003e\r\n \t\u003cli\u003eSupporting Long-Term Patient Outcomes\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program integrates multiple specialties into a practical primary care educational framework.\r\n\u003ch2\u003eOfficial Faculty\u003c\/h2\u003e\r\nThe Session I agenda identifies the following presenters:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eW. Ejnes, CHCP\u003c\/strong\u003e — Conference Announcements\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eP. Buch, MD\u003c\/strong\u003e — Hepatology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eA. Urban, MD\u003c\/strong\u003e — Infectious Diseases\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eC. Shufelt, MD\u003c\/strong\u003e — Women's Health and Cardiovascular Prevention\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eL. Rogo-Gupta, MD\u003c\/strong\u003e — Urogynecology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eJ. Basile, MD\u003c\/strong\u003e — Hypertension\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eW. Weart, PharmD\u003c\/strong\u003e — Clinical Pharmacology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eR. Dachs, MD\u003c\/strong\u003e — Emergency and Vascular Medicine\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eT. Heinrich, MD\u003c\/strong\u003e — Psychiatry\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eM. Vaezi, MD\u003c\/strong\u003e — Gastroenterology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eG. Day, MD\u003c\/strong\u003e — Neurology and Dementia\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese faculty members cover a broad range of clinically important subjects relevant to internal medicine and outpatient primary care.\r\n\u003ch2\u003eContinuing Medical Education\u003c\/h2\u003e\r\nContinuing Education Company advertised up to \u003cstrong\u003e20 CME credits\u003c\/strong\u003e for the original 2025 Primary Care Spring Conference.\r\n\r\nThe original educational program was delivered through in-person and live webcast participation.\r\n\r\nOfficial eligibility, continuing education credits, documentation, and certificates were governed by CEC's participation and completion requirements.\r\n\u003ch3\u003eImportant CME Notice\u003c\/h3\u003e\r\nPurchasing separately distributed educational materials through MedicalAmboss does not provide:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOfficial CEC CME Credits\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial Completion Certificates\u003c\/li\u003e\r\n \t\u003cli\u003eConference Registration\u003c\/li\u003e\r\n \t\u003cli\u003eLive Conference Attendance\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher Webcast Access\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial CEC Online Accounts\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher Memberships\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher-Hosted Educational Extras\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Relevant\u003c\/h2\u003e\r\nThe \u003cstrong\u003eContinuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I\u003c\/strong\u003e provides a multidisciplinary review of medical conditions commonly encountered by primary care physicians.\r\n\r\nThe curriculum addresses:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLiver Disease\u003c\/li\u003e\r\n \t\u003cli\u003eOutpatient Infections\u003c\/li\u003e\r\n \t\u003cli\u003eCellulitis\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular Risk in Women\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eUrinary Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Updates\u003c\/li\u003e\r\n \t\u003cli\u003eSyncope\u003c\/li\u003e\r\n \t\u003cli\u003eVenous Thromboembolism\u003c\/li\u003e\r\n \t\u003cli\u003eDepression\u003c\/li\u003e\r\n \t\u003cli\u003eGERD\u003c\/li\u003e\r\n \t\u003cli\u003eDementia\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nIts integration of diagnostic updates, therapeutic guidance, pharmacology, preventive medicine, and clinical decision-making makes it particularly relevant to internists, family physicians, and other healthcare professionals seeking continuing education in primary care.\r\n\u003ch2\u003eOfficial Program Reference and MedicalAmboss Purchase Scope\u003c\/h2\u003e\r\n\u003cstrong\u003eContinuing Education Company:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/www.cmemeeting.org\/\" data-rich-text-autolink=\"\"\u003ehttps:\/\/www.cmemeeting.org\/\u003c\/a\u003e\r\n\r\n\u003cstrong\u003eMedicalAmboss Product:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/medicalamboss.com\/product\/cec-19th-annual-primary-care-spring-conference-2025\/\" data-rich-text-autolink=\"\"\u003ehttps:\/\/medicalamboss.com\/product\/cec-19th-annual-primary-care-spring-conference-2025\/\u003c\/a\u003e\r\n\r\nThe course information and lecture titles are based on the published 2025 Session I agenda.\r\n\r\nThe original event program does not independently verify the inventory, runtime, or completeness of files included in the MedicalAmboss product.\r\n\r\n\u003cstrong\u003eMedicalAmboss File Scope:\u003c\/strong\u003e This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eShort Description\u003c\/h2\u003e\r\n\u003cstrong\u003eCEC 19th Annual Primary Care Spring Conference 2025 – Session I\u003c\/strong\u003e provides a comprehensive, evidence-based educational update in family medicine, internal medicine, hepatology, infectious diseases, women's health, cardiology, clinical pharmacology, psychiatry, gastroenterology, and neurology.\r\n\r\nHeld March 31 – April 4, 2025, in Palm Coast, Florida, the original conference features expert clinical presentations on elevated liver function tests, MASLD, antibiotics, cellulitis, menopause, overactive bladder, hypertension, syncope, VTE, depression, GERD, dementia, and Alzheimer's disease.\r\n\u003ch3 class=\"\" data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003eTopics (Session I)\u003c\/b\u003e\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"11\"\u003e\u003cb data-path-to-node=\"11\" data-index-in-node=\"0\"\u003eMONDAY, March 31, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"13\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,0,0\"\u003e\u003cb data-path-to-node=\"13,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"13,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,1,0\"\u003e\u003cb data-path-to-node=\"13,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Boot Camp for Elevated Liver Function Tests — \u003ci data-path-to-node=\"13,1,0\" data-index-in-node=\"65\"\u003eP. Buch, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,2,0\"\u003e\u003cb data-path-to-node=\"13,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) — \u003ci data-path-to-node=\"13,2,0\" data-index-in-node=\"87\"\u003eP. Buch, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-649\" data-path-to-node=\"13,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"13,3,0,0\"\u003e\u003cb data-path-to-node=\"13,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,4,0\"\u003e\u003cb data-path-to-node=\"13,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e More Head to Toes Antibiotics: Treatment Decisions for Common Outpatient Infections — \u003ci data-path-to-node=\"13,4,0\" data-index-in-node=\"107\"\u003eA. Urban, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,5,0\"\u003e\u003cb data-path-to-node=\"13,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Cellulitis in Adults: Improving Care and Calming Red-Hot Literature — \u003ci data-path-to-node=\"13,5,0\" data-index-in-node=\"91\"\u003eA. Urban, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"14\"\u003e\u003cb data-path-to-node=\"14\" data-index-in-node=\"0\"\u003eTUESDAY, April 1, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"16\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"16,0,0\"\u003e\u003cb data-path-to-node=\"16,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"16,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"16,1,0\"\u003e\u003cb data-path-to-node=\"16,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Targeting Women at Risk of CVD at Midlife: A Challenge to the Physician — \u003ci data-path-to-node=\"16,1,0\" data-index-in-node=\"93\"\u003eC. Shufelt, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"16,2,0\"\u003e\u003cb data-path-to-node=\"16,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Management of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows — \u003ci data-path-to-node=\"16,2,0\" data-index-in-node=\"128\"\u003eC. Shufelt, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-656\" data-path-to-node=\"16,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"16,3,0,0\"\u003e\u003cb data-path-to-node=\"16,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"16,4,0\"\u003e\u003cb data-path-to-node=\"16,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e How to Address Overactive Bladder in Primary Care — \u003ci data-path-to-node=\"16,4,0\" data-index-in-node=\"73\"\u003eL. Rogo-Gupta, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"16,5,0\"\u003e\u003cb data-path-to-node=\"16,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e How to Address Pelvic Symptoms in Postpartum Patients Transitioning Back to Primary Care — \u003ci data-path-to-node=\"16,5,0\" data-index-in-node=\"112\"\u003eL. Rogo-Gupta, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"17\"\u003e\u003cb data-path-to-node=\"17\" data-index-in-node=\"0\"\u003eWEDNESDAY, April 2, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"19\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,0,0\"\u003e\u003cb data-path-to-node=\"19,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"19,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,1,0\"\u003e\u003cb data-path-to-node=\"19,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Controversies in Hypertension: Testing What You Know — \u003ci data-path-to-node=\"19,1,0\" data-index-in-node=\"74\"\u003eJ. Basile, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,2,0\"\u003e\u003cb data-path-to-node=\"19,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Resistant Hypertension: An Update — \u003ci data-path-to-node=\"19,2,0\" data-index-in-node=\"56\"\u003eJ. Basile, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-663\" data-path-to-node=\"19,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"19,3,0,0\"\u003e\u003cb data-path-to-node=\"19,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,4,0\"\u003e\u003cb data-path-to-node=\"19,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e New Drug Update — \u003ci data-path-to-node=\"19,4,0\" data-index-in-node=\"39\"\u003eW. Weart, PharmD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,5,0\"\u003e\u003cb data-path-to-node=\"19,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Ask the Expert: Pharmacology Q\u0026amp;A — \u003ci data-path-to-node=\"19,5,0\" data-index-in-node=\"56\"\u003eW. Weart, PharmD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"20\"\u003e\u003cb data-path-to-node=\"20\" data-index-in-node=\"0\"\u003eTHURSDAY, April 3, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"22\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"22,0,0\"\u003e\u003cb data-path-to-node=\"22,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"22,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"22,1,0\"\u003e\u003cb data-path-to-node=\"22,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Syncope: What to Do When the Lights Go Out? — \u003ci data-path-to-node=\"22,1,0\" data-index-in-node=\"65\"\u003eR. Dachs, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"22,2,0\"\u003e\u003cb data-path-to-node=\"22,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Venous Thromboembolism and the D-Dimer: 1) The Case of the Swollen Calf and 2) The Case of Pleuritic Chest Pain — \u003ci data-path-to-node=\"22,2,0\" data-index-in-node=\"134\"\u003eR. Dachs, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-670\" data-path-to-node=\"22,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"22,3,0,0\"\u003e\u003cb data-path-to-node=\"22,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"22,4,0\"\u003e\u003cb data-path-to-node=\"22,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e A Primary Care Perspective on the Treatment of Depression: SSRIs and Beyond — \u003ci data-path-to-node=\"22,4,0\" data-index-in-node=\"99\"\u003eT. Heinrich, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"22,5,0\"\u003e\u003cb data-path-to-node=\"22,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Side Effects of Psychiatric Medications — \u003ci data-path-to-node=\"22,5,0\" data-index-in-node=\"63\"\u003eT. Heinrich, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"23\"\u003e\u003cb data-path-to-node=\"23\" data-index-in-node=\"0\"\u003eFRIDAY, April 4, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"25\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"25,0,0\"\u003e\u003cb data-path-to-node=\"25,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"25,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"25,1,0\"\u003e\u003cb data-path-to-node=\"25,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 10:00 am:\u003c\/b\u003e GERD and Extraesophageal GERD: How to Test and Treat? — \u003ci data-path-to-node=\"25,1,0\" data-index-in-node=\"76\"\u003eM. Vaezi, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-676\" data-path-to-node=\"25,2,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"25,2,0,0\"\u003e\u003cb data-path-to-node=\"25,2,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"25,3,0\"\u003e\u003cb data-path-to-node=\"25,3,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e A True Clinic-based Approach to Dementia — \u003ci data-path-to-node=\"25,3,0\" data-index-in-node=\"64\"\u003eG. Day, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"25,4,0\"\u003e\u003cb data-path-to-node=\"25,4,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Clinical Findings and Approach to Management in Alzheimer Disease — \u003ci data-path-to-node=\"25,4,0\" data-index-in-node=\"89\"\u003eG. Day, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-678\" data-path-to-node=\"25,4,1\"\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 class=\"\" data-path-to-node=\"28\"\u003e\u003cb data-path-to-node=\"28\" data-index-in-node=\"0\"\u003e19TH ANNUAL PRIMARY CARE SPRING CONFERENCE 2025 – SESSION II\u003c\/b\u003e\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"30\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"30,0,0\"\u003e\u003cb data-path-to-node=\"30,0,0\" data-index-in-node=\"0\"\u003eConference Title:\u003c\/b\u003e 19th Annual Primary Care Spring Conference – Session II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"30,1,0\"\u003e\u003cb data-path-to-node=\"30,1,0\" data-index-in-node=\"0\"\u003eOrganizer:\u003c\/b\u003e Continuing Education Company, Inc. (CEC)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-679\" data-path-to-node=\"30,2,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"30,2,0,0\"\u003e\u003cb data-path-to-node=\"30,2,0,0\" data-index-in-node=\"0\"\u003eDates:\u003c\/b\u003e April 14–18, 2025\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"30,3,0\"\u003e\u003cb data-path-to-node=\"30,3,0\" data-index-in-node=\"0\"\u003eLocation:\u003c\/b\u003e Hammock Beach Golf Resort \u0026amp; Spa, Palm Coast, Florida, USA (In-Person and Live Streaming Webcast)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-680\" data-path-to-node=\"30,5,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"30,5,0,0\"\u003e\u003cb data-path-to-node=\"30,5,0,0\" data-index-in-node=\"0\"\u003eDescription:\u003c\/b\u003e The 19th Annual Primary Care Spring Conference (Session\u003cspan class=\"citation-30408 citation-30409 citation-30411 citation-30412 citation-30415 citation-30416\"\u003e II), organized by the Continuing Education Company (CEC), is a\u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-30411 citation-30412 citation-30413 citation-30414 citation-30415 citation-30416\"\u003e 5-day live and virtual event held at the Hammock Beach Golf Resort \u0026amp; Spa in Palm Coast, Florida. The curriculum provides evidence-based \u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-30410 citation-30411 citation-30412 citation-30413 citation-30414 citation-30415 citation-30416 citation-end-30416\"\u003eclinical updates across Hepatology, Hypertension, Women’s Health \u0026amp; Menopause, Cardiovascular-Kidney\u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-30410 citation-30411 citation-30412 citation-30413 citation-end-30413\"\u003e-Metabolic (CKM) Sy\u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-30410 citation-30411 citation-30412 citation-end-30412\"\u003endrome, Obesity Medicine, Psychiatry, G\u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-30410 citation-end-30410\"\u003eastroenterology, Emergency\/Vascular Medicine, Neurology (Migraine, Dementia, Alzheimer’s Dis\u003c\/span\u003e\u003cspan class=\"citation-30408 citation-30409 citation-end-30409\"\u003eease), and Clin\u003c\/span\u003eical Pharmacology\u003c\/span\u003e\u003cspan data-path-to-node=\"30,5,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 class=\"\" data-path-to-node=\"31\"\u003e\u003cb data-path-to-node=\"31\" data-index-in-node=\"0\"\u003eLearning Objectives\u003c\/b\u003e\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"32\"\u003eAs a result of this conference, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"33\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"33,0,0\"\u003eAssess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"33,1,0\"\u003eUtilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"33,2,0\"\u003eFormulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long-term outcomes.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-681\" data-path-to-node=\"33,3,0\"\u003e\u003cspan data-path-to-node=\"33,3,0,0\"\u003eApply practical diagnostic and management strategies for elevated liver function tests, metabolic dysfunction-associated steatotic liver disease (MASLD), and GERD\/extraesophageal GERD\u003c\/span\u003e\u003cspan data-path-to-node=\"33,3,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-682\" data-path-to-node=\"33,4,0\"\u003e\u003cspan data-path-to-node=\"33,4,0,0\"\u003eManage complex cardiovascular and metabolic conditions, including resistant hypertension, midlife CVD risk in women, Cardiovascular-Kidney-Metabolic (CKM) syndrome, and obesity-related cardiovascular disease\u003c\/span\u003e\u003cspan data-path-to-node=\"33,4,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-683\" data-path-to-node=\"33,5,0\"\u003e\u003cspan data-path-to-node=\"33,5,0,0\"\u003eEvaluate and treat depression, psychiatric medication side effects, migraine headaches, dementia, and Alzheimer’s disease in the outpatient setting\u003c\/span\u003e\u003cspan data-path-to-node=\"33,5,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-684\" data-path-to-node=\"33,6,0\"\u003e\u003cspan data-path-to-node=\"33,6,0,0\"\u003eUtilize evidence-based diagnostic pathways for syncope, venous thromboembolism (VTE), and newly approved pharmacological agents\u003c\/span\u003e\u003cspan data-path-to-node=\"33,6,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 class=\"\" data-path-to-node=\"34\"\u003e\u003cb data-path-to-node=\"34\" data-index-in-node=\"0\"\u003eTarget Audience\u003c\/b\u003e\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"35\"\u003eThis course is intended for primary care physicians, family medicine physicians, internists, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals involved in outpatient and primary care medicine.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"35\"\u003eBest for Primary Care Physicians, Family Physicians, Internists, Hepatologists, Gastroenterologists, Endocrinologists, Cardiologists, Nephrologists, Gynecologists, Obstetricians and Gynecologists (OB-GYNs), Psychiatrists, Emergency Medicine Physicians, Hematologists, Pulmonologists, and Neurologists.\u003c\/p\u003e\r\n\r\n\u003ch3 class=\"\" data-path-to-node=\"36\"\u003e\u003cb data-path-to-node=\"36\" data-index-in-node=\"0\"\u003eTopics (Session II)\u003c\/b\u003e\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"37\"\u003e\u003cb data-path-to-node=\"37\" data-index-in-node=\"0\"\u003eMONDAY, April 14, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"39\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"39,0,0\"\u003e\u003cb data-path-to-node=\"39,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"39,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"39,1,0\"\u003e\u003cb data-path-to-node=\"39,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Boot Camp for Elevated Liver Function Tests: A Practical Approach for Primary Care — \u003ci data-path-to-node=\"39,1,0\" data-index-in-node=\"104\"\u003eF. Pasquel, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"39,2,0\"\u003e\u003cb data-path-to-node=\"39,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) — \u003ci data-path-to-node=\"39,2,0\" data-index-in-node=\"87\"\u003eF. Pasquel, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-689\" data-path-to-node=\"39,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"39,3,0,0\"\u003e\u003cb data-path-to-node=\"39,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"39,4,0\"\u003e\u003cb data-path-to-node=\"39,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e Controversies in Hypertension: Testing What You Know — \u003ci data-path-to-node=\"39,4,0\" data-index-in-node=\"76\"\u003eJ. Basile, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"39,5,0\"\u003e\u003cb data-path-to-node=\"39,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Resistant Hypertension: An Update — \u003ci data-path-to-node=\"39,5,0\" data-index-in-node=\"57\"\u003eJ. Basile, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"40\"\u003e\u003cb data-path-to-node=\"40\" data-index-in-node=\"0\"\u003eTUESDAY, April 15, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"42\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"42,0,0\"\u003e\u003cb data-path-to-node=\"42,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"42,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"42,1,0\"\u003e\u003cb data-path-to-node=\"42,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Targeting Women at Risk of CVD at Midlife: A Challenge to the Physician — \u003ci data-path-to-node=\"42,1,0\" data-index-in-node=\"93\"\u003eC. Shufelt, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"42,2,0\"\u003e\u003cb data-path-to-node=\"42,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Management of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows — \u003ci data-path-to-node=\"42,2,0\" data-index-in-node=\"128\"\u003eC. Shufelt, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-696\" data-path-to-node=\"42,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"42,3,0,0\"\u003e\u003cb data-path-to-node=\"42,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"42,4,0\"\u003e\u003cb data-path-to-node=\"42,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Evolving Priorities for Cardiovascular Prevention and Management — \u003ci data-path-to-node=\"42,4,0\" data-index-in-node=\"136\"\u003eC. Ndumele, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"42,5,0\"\u003e\u003cb data-path-to-node=\"42,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Addressing the Link Between Obesity and Cardiovascular Disease — \u003ci data-path-to-node=\"42,5,0\" data-index-in-node=\"86\"\u003eC. Ndumele, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"43\"\u003e\u003cb data-path-to-node=\"43\" data-index-in-node=\"0\"\u003eWEDNESDAY, April 16, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"45\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"45,0,0\"\u003e\u003cb data-path-to-node=\"45,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"45,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"45,1,0\"\u003e\u003cb data-path-to-node=\"45,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e The Treatment of Depression: SSRIs and Beyond — \u003ci data-path-to-node=\"45,1,0\" data-index-in-node=\"67\"\u003eT. Heinrich, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"45,2,0\"\u003e\u003cb data-path-to-node=\"45,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Side Effects of Psychiatric Medications — \u003ci data-path-to-node=\"45,2,0\" data-index-in-node=\"62\"\u003eT. Heinrich, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-703\" data-path-to-node=\"45,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"45,3,0,0\"\u003e\u003cb data-path-to-node=\"45,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"45,4,0\"\u003e\u003cb data-path-to-node=\"45,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 12:15 pm:\u003c\/b\u003e GERD and Extraesophageal GERD: How to Test and Treat? — \u003ci data-path-to-node=\"45,4,0\" data-index-in-node=\"77\"\u003eM. Vaezi, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"46\"\u003e\u003cb data-path-to-node=\"46\" data-index-in-node=\"0\"\u003eTHURSDAY, April 17, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"48\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"48,0,0\"\u003e\u003cb data-path-to-node=\"48,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"48,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"48,1,0\"\u003e\u003cb data-path-to-node=\"48,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e Syncope: What to do When the Lights Go Out — \u003ci data-path-to-node=\"48,1,0\" data-index-in-node=\"64\"\u003eR. Dachs, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"48,2,0\"\u003e\u003cb data-path-to-node=\"48,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Venous Thromboembolism and the D-Dimer: The Case of the Swollen Calf and the Case of Pleuritic Chest Pain — \u003ci data-path-to-node=\"48,2,0\" data-index-in-node=\"128\"\u003eR. Dachs, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-709\" data-path-to-node=\"48,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"48,3,0,0\"\u003e\u003cb data-path-to-node=\"48,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"48,4,0\"\u003e\u003cb data-path-to-node=\"48,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e Diagnosis of Migraine — \u003ci data-path-to-node=\"48,4,0\" data-index-in-node=\"45\"\u003eJ. Ailani, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"48,5,0\"\u003e\u003cb data-path-to-node=\"48,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Migraine State of the Art — \u003ci data-path-to-node=\"48,5,0\" data-index-in-node=\"49\"\u003eJ. Ailani, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"49\"\u003e\u003cb data-path-to-node=\"49\" data-index-in-node=\"0\"\u003eFRIDAY, April 18, 2025\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"51\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"51,0,0\"\u003e\u003cb data-path-to-node=\"51,0,0\" data-index-in-node=\"0\"\u003e7:55 am – 8:00 am:\u003c\/b\u003e Conference Announcements — \u003ci data-path-to-node=\"51,0,0\" data-index-in-node=\"46\"\u003eW. Ejnes, CHCP\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"51,1,0\"\u003e\u003cb data-path-to-node=\"51,1,0\" data-index-in-node=\"0\"\u003e8:00 am – 9:00 am:\u003c\/b\u003e A True Clinic-based Approach to Dementia — \u003ci data-path-to-node=\"51,1,0\" data-index-in-node=\"62\"\u003eG. Day, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"51,2,0\"\u003e\u003cb data-path-to-node=\"51,2,0\" data-index-in-node=\"0\"\u003e9:00 am – 10:00 am:\u003c\/b\u003e Clinical Findings and Approach to Management in Alzheimer Disease — \u003ci data-path-to-node=\"51,2,0\" data-index-in-node=\"88\"\u003eG. Day, MD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_3317ee388a467eae-716\" data-path-to-node=\"51,3,0\"\u003e\u003cspan class=\"\" data-path-to-node=\"51,3,0,0\"\u003e\u003cb data-path-to-node=\"51,3,0,0\" data-index-in-node=\"0\"\u003e10:00 am:\u003c\/b\u003e BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"51,4,0\"\u003e\u003cb data-path-to-node=\"51,4,0\" data-index-in-node=\"0\"\u003e10:15 am – 11:15 am:\u003c\/b\u003e New Drug Update — \u003ci data-path-to-node=\"51,4,0\" data-index-in-node=\"39\"\u003eC. Weart, PharmD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"51,5,0\"\u003e\u003cb data-path-to-node=\"51,5,0\" data-index-in-node=\"0\"\u003e11:15 am – 12:15 pm:\u003c\/b\u003e Ask the Expert: Pharmacology Q\u0026amp;A — \u003ci data-path-to-node=\"51,5,0\" data-index-in-node=\"56\"\u003eC. Weart, PharmD\u003c\/i\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":67982435811482,"sku":"MED-AMB10545","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/macs-0efe51bcb5-51087-51088-05710af903b6bf251ba5.jpg?v=1793146382","url":"https:\/\/ambosscourse.com\/products\/wc-0efe51bcb5f34c14-51087","provider":"Amboss","version":"1.0","type":"link"}